| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |